Akcea Therapeutics Inc., of Boston, appointed Damien McDevitt CEO.
Cytomx Therapeutics Inc., of South San Francisco, appointed Carlos Campoy senior vice president and chief financial officer.
Epimab Biotherapeutics Inc., of Shanghai, appointed David Gu chief financial officer.
Mannkind Corp., of Westlake Village, Calif., appointed Jennifer Grancio to its board.
Menlo Therapeutics Inc., of Bridgewater, N.J., appointed Andrew Saik chief financial officer and treasurer.
Nordic Nanovector ASA, of Oslo, Norway, appointed Dominic Smethurst interim chief medical officer.
PDS Biotechnology Corp., of Princeton, N.J., appointed President and CEO Frank Bedu-Addo interim principal financial officer and Controller Janetta Trochimiuk interim principal accounting officer.
Revive Therapeutics Ltd., of Toronto, appointed David Boulware scientific advisor for infectious diseases.
Saniona AB, of Ballerup, Denmark, appointed Anita Milland interim chief financial officer and head of investor relations and Jorgen Drejer deputy CEO.